Chevron, Eli Lilly, Honeywell, Bausch Health


“I like Chevron because I just think that oil is still undervalued even after last year. The oils have newfound discipline,” Cramer said. He also noted that in September, Chevron announced it planned to triple capital investment in its lower-carbon energy units. Chevron is up nearly 42% over the past 12 months and just over 5% already in 2022.

Cramer highlighted Eli Lilly’s experimental Alzheimer’s treatment, called donanemab, as well as a diabetes drug “that’s going to be big” called tirzepatide. Cramer said another reason he’s attracted to Eli Lilly shares is because he thinks overall sentiment toward drug companies is too negative. While Lilly is up nearly 59% over the past 12 months,…


0 0 votes
Article Rating

Cramer says it’s impossible to recommend Chinese stocks in a hostile communist regime

Previous article

Daimler’s concept car uses bio-based materials, has solar tech on roof

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Investing